Back to IDIX Stock Lookup

IDIX Related Analyst Ratings

May 2, 2013 01:45 PM Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank

Feb 11, 2013 04:26 PM Baird Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral; No Great Pipeline but Patents Could Have Value

Jan 30, 2013 07:15 AM Wedbush Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Neutral

Nov 28, 2012 06:49 AM Deutsche Bank Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy

Nov 12, 2012 03:04 PM Maxim Group Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold

Sep 19, 2012 06:28 AM BofA/Merrill Lynch Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Neutral

Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)

Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead

Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution

Aug 17, 2012 07:45 AM Jefferies Maintains a 'Hold' on Gilead Sciences (GILD); We Don't Believe

Aug 17, 2012 07:32 AM Brean Murray Carret & Co. Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold; IDX184 on Clinical Hold Again

Aug 16, 2012 12:27 PM Stifel Nicolaus Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold

Aug 16, 2012 10:53 AM Deutsche Bank Defends Gilead Sciences (GILD) on Sector Setback

Jul 20, 2012 12:25 PM UPDATE: UBS Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy: Keys To Success

Jun 14, 2012 08:44 AM Maxim Group Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy

May 24, 2012 05:14 PM Brean Murray Sees Recent Upside in Idenix (IDIX) Related to Possible Gilead (GILD) Settlement in June

Apr 30, 2012 08:20 AM JMP Securities Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Market Perform

Apr 17, 2012 07:47 AM Credit Suisse Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Neutral

Apr 4, 2012 12:57 PM Idenix (IDIX) Shares at Intraday Low; INFORM-SVR Data Has Negative Implications & Abbott (ABT) Positive Hep C Studies

Mar 27, 2012 01:04 PM Wedbush Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Outperform; Market Potential for IDX184 Makes For Attractive Takeover Candidate

Mar 13, 2012 10:45 AM Leerink Swann Maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Addressing USPTO Interference For GILD/ IDIX Patent Claims

Feb 24, 2012 09:30 AM Wedbush Raises Price Target on Idenix Pharmaceuticals (IDIX) Following Pipeline Update

Feb 24, 2012 09:08 AM Brean Murray Carret & Co. Maintains a 'Sell' on Idenix Pharmaceuticals (IDIX); Hep C Pipeline Progresses, But Future Development Strategy Appears Risky

Feb 10, 2012 02:30 PM Barclays on U.S. Pharma: A New Era for Hep C Therapy - Starts Coverage on GILD & IDIX

Feb 10, 2012 08:05 AM Barclays Starts Idenix Pharmaceuticals (IDIX) at Equalweight

Feb 3, 2012 02:57 PM William Blair Lifts Target on Idenix (IDIX) to $14 Following Removal of Clinical Hold

Feb 3, 2012 08:25 AM Brean Murray Raises Red Flag on Idenix (IDIX) After GS-7977 Data from Gilead

Jan 27, 2012 09:17 AM Idenix Pharmaceuticals (IDIX) Slammed As Shares Slapped with a "Sell"

Jan 27, 2012 07:47 AM Stifel Nicolaus Downgrades Idenix Pharmaceuticals (IDIX) to Sell

Jan 18, 2012 01:18 PM Big Pharma Companies Drooling Over Idenix (IDIX) Following BMY/INHX Deal

Jan 9, 2012 03:24 PM JMP Cuts Idenix (IDIX) to Market Underperform, Sets $4 Price Target

Jan 9, 2012 10:36 AM Wall Street Hot and Bothered About Idenix (IDIX) and Achillion (ACHN) After INHX/BMY Deal

Dec 23, 2011 07:26 AM Brean Murray Carret & Co. Maintains a 'Sell' on Idenix Pharmaceuticals (IDIX); GSK Termination of HIV License is a Non-Event

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Nov 29, 2011 08:03 AM William Blair Upgrades Idenix Pharmaceuticals (IDIX) to Outperform

Nov 15, 2011 07:51 AM Wedbush Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Outperform; Expect Growing Visibility for IDX184

Oct 18, 2011 08:16 AM Wedbush Downgrades Anadys Pharmaceuticals (ANDS) to Neutral; Announces Acquisition by Roche; Additional Takeover Targets Remain

Jul 26, 2011 07:43 AM Wedbush Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral; IDX184 Has Blockbuster Potential, But Current Risk/Reward Balanced

Jul 25, 2011 07:39 AM JPMorgan Starts Idenix Pharmaceuticals Inc. (IDIX) at Overweight

Jun 2, 2011 10:24 AM Brean Murray Carret & Co. Starts Idenix Pharmaceuticals Inc. (IDIX) at Sell, $3 Price Target

Apr 11, 2011 08:45 AM BofA/Merrill Lynch Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Buy

Mar 18, 2011 09:13 AM Morgan Stanley Starts Idenix Pharmaceuticals Inc. (IDIX) at Equalweight

Feb 10, 2011 08:21 AM ThinkEquity Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Sell

Feb 10, 2011 07:34 AM Stifel Nicolaus Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold

Feb 10, 2011 07:12 AM Oppenheimer Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Perform

Feb 4, 2011 08:12 AM BofA/Merrill Lynch Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral

Oct 27, 2010 12:34 PM Gleacher & Co Initiates Coverage on Biotechnology/Drug Manufacturers Stocks (IDIX, VRUS, & VRTX)

Sep 8, 2010 08:55 AM JMP Securities Downgrades Idenix Pharma (IDIX) to Market Perform

Jul 14, 2010 08:15 AM Stifel Nicolaus Initiates Coverage on Idenix Pharmaceuticals (IDIX) with a Buy

Back to IDIX Stock Lookup